Talk:Darolutamide
Appearance
This is the talk page for discussing improvements to the Darolutamide article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Darolutamide.
|
This article is rated B-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||
|
INTREPId Study
[edit]Note the multicentered Darolutamide clinical trials.[1] MaynardClark (talk) 04:30, 16 February 2024 (UTC)
References
Long-term outcomes after treatment
[edit]Doesn't this article NEED some knowledge about long-term outcomes after treatment in research subjects (and also in clinical experience after years of treating patients). Is there no other way to discuss these issues without sounding like the pharmaceutical marketing literature? MaynardClark (talk) 04:30, 16 February 2024 (UTC)